Home / World Marketplace / Archive by category Global Health & Biotech (Page 45)

Archive by category Global Health & Biotech

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinics The program, launching this month, will run for a minimum of three years PARSIPPANY, N.J., Dec. 11, 2024 (Korea Bizwire) – Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a new patient access [...]

GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

Former CEO of NPS Pharma brings strong biotech expertise to further accelerate GEn1E’s development and commercialization of dual signal modulators as novel precision therapies PALO ALTO, Calif., Dec. 11, 2024 (Korea Bizwire) – GEn1E Lifesciences (GEn1E), a clinical-stage, Phase 2 company, focused on accelerating novel therapies for inflammatory and rare diseases using machine learning, is [...]

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (Korea Bizwire) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal injection with their formulation in facial skin. AIV001 is [...]

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

AJOVY® (fremanezumab) significantly reduced monthly migraine days (MMD) and monthly headache days (MHD) versus placebo over a 12-week period in pediatric patients aged 6-17 years1 Efficacy consistent with fremanezumab pivotal Phase 3 and Real-World Evidence studies in adults with no new emergent safety signals observed Full data presented as a late breaker at European Headache Congress (EHC) 4-7 December in [...]

Philips aims to advance cardiac MRI technology through AI-driven research

December 3, 2024 Collaboration intends to leverage proprietary AI technology from Philips and Mayo Clinic to target breakthroughs in ease-of-use and efficiency to bring high-quality diagnostic MRI and better care to more patients with heart disease Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic today announced a research collaboration aimed at advancing [...]

Canon Medical Informatics Selected by Major Non-Profit Health System to Standardize Advanced Visualization Across 25+ Locations

MINNETONKA, Minn., Dec. 03, 2024 (Korea Bizwire) – Canon Medical Informatics, Inc. today announced that a leading non-profit health system in the Mid-Atlantic region has chosen Canon’s Vitrea® Advanced Visualization enterprise platform to consolidate its 3D imaging capabilities across more than 25 sites. This transition from a multi-vendor setup to a unified, integrated solution will help [...]

Canon Medical Informatics Selected by Leading U.S. Health System to Standardize 3D Processing Capabilities in the Cloud Using Vitrea Advanced Visualization Platform

MINNETONKA, Minn., Dec. 02, 2024 (Korea Bizwire) – Canon Medical Informatics, Inc. has been selected by a leading U.S. health system to standardize advanced imaging capabilities across 6 sites using the Vitrea Advanced Visualization enterprise platform. By leveraging their privately managed cloud infrastructure, the health system achieves scalable, secure, and cost-efficient access to cutting-edge imaging [...]

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024

December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications Philips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize time-sensitive cases Amsterdam, the Netherlands and Chicago, USA – Royal [...]

Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24

December 1, 2024 Philips’ intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number of patients Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled the company’s latest AI-powered diagnostic [...]

Kyung-Ah Kim Named as President and Chief Executive Officer of Samsung Bioepis

First time in Samsung’s history to name a non-founder female Chief Executive Officer INCHEON, South Korea, Nov. 27, 2024 (Korea Bizwire) – Samsung Bioepis Co., Ltd. today announced that Kyung-Ah Kim, who has been serving as Executive Vice President and Development Division Leader, has been named as President and Chief Executive Officer of Samsung Bioepis. [...]